Eagan, MN, United States of America

Sarah A Strong

This inventor holds 24 USPTO granted patents, plus 2 CIPO patents and 7 EPO patents, primarily in Antibacterial Compounds. Top assignees: N30 Pharmaceuticals, Inc., Crestone, Inc., Nivalis Therapeutics, Inc.. Active years: 2006-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sarah A Strong. Retrieved from https://idiyas.com/inventor/sarah-a-strong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 25.0


 

Average Co-Inventor Count = 5.6

ph-index = 7

Forward Citations = 408(Granted Patents)


Location History:

  • Eagan, MN (US) (2006 - 2009)
  • Louisville, CO (US) (2009 - 2017)

Company Filing History:


Years Active: 2006-2017

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pyrrole Inhibitors
S-Nitrosoglutathione Reductase
Antibacterial Activity
Thienopyridone Compounds
Pyrazolopyridines
Heterocyclic Ureas
Clostridium Treatment
Enantiomeric Compounds
Aryl Substituted Imidazoquinolines
Antibacterial Sulfones
Antibacterial Amides
Substituted Phenylether
24 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sarah A. Strong in Pharmaceutical Development

Introduction: Sarah A. Strong, based in Eagan, Minnesota, is a prolific inventor with an impressive portfolio of 24 patents. Her groundbreaking work primarily focuses on pharmaceutical compositions and therapeutic agents, particularly in the realm of GSNOR (S-nitrosoglutathione reductase) inhibitors.

Latest Patents: Among her recent innovations is a patent for pyrrole inhibitors of S-nitrosoglutathione reductase, which are essential as therapeutic agents. This invention outlines the development of these inhibitors, the pharmaceutical compositions that include them, and the methods for their application. This work aims to advance treatment options for various medical conditions by targeting GSNOR effectively.

Career Highlights: Throughout her career, Sarah has worked with notable companies such as N30 Pharmaceuticals, Inc. and Crestone, Inc. Her contributions have significantly influenced the development of novel therapeutics in the biomedical field, showcasing her commitment to innovation and science.

Collaborations: Sarah has collaborated with talented individuals in her field, including Xicheng David Sun and Jian Qiu. These partnerships have fostered a dynamic environment for research and development, allowing for a collective approach to tackling complex pharmaceutical challenges.

Conclusion: Sarah A. Strong exemplifies the spirit of innovation and dedication in the field of pharmaceuticals. With her extensive patent portfolio and collaborative efforts, she continues to contribute valuable advancements that benefit healthcare and therapeutic applications. Her work is a testament to the impact that determined inventors can have on society.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…